We constructed a set of deletions upstream of the gcv promoter and analyzed the effects of the deletions on expression of a gcvT-lacZ gene fusion. A deletion that ends at position -313 upstream of the transcription initiation site (+1) results in reduced levels ofgcvT-lacZ expression, but the fusion is still inducible by glycine and repressible by purines. A deletion that ends at position -169 results in loss of both GcvA-and Lrp-mediated activation of the gcvT-lacZ fusion. The endpoints of A-313 and A-169 also define a site that down-regulates gcvT-lacZ expression two-to threefold. A deletion that ends at position -89 upstream from the transcription initiation site still shows PurR-mediated repression, suggesting that PurR-mediated repression is not by direct interference with the GcvA-and Lrp-mediated regulatory mechanism(s). Gel mobility shift assays and DNase I footprinting showed that Lrp protein binds to multiple sites upstream of the gcv promoter, from about bp -92 to bp -229. The results suggest that the gcv regulatory region is complex, with numerous cis-acting sites that are required for normal gcv expression.
Serine hydroxymethyltransferase catalyzes the conversion of serine to glycine and 5,10-methylenetetrahydrofolate and is the major source of one-carbon units for cell metabolism (14) . The glycine cleavage (GCV) enzyme system catalyzes the oxidative cleavage of glycine to carbon dioxide, ammonia, and 5,10-methylenetetrahydrofolate and provides a secondary pathway for one-carbon biosynthesis (8, 12, 20) . The GCV enzymes, however, have only about 1/10 the activity of serine hydroxymethyltransferase (8) . The low activity of the GCV enzyme system is believed to ensure that sufficient levels of glycine are maintained for other pathways that require this amino acid (purine synthesis and protein synthesis, etc.).
The GCV enzyme system is inducible by glycine, and at least two proteins, GcvA (31) and Lrp (10) , are required for gcv expression. GcvA activates gcv expression in the presence of exogenous glycine and represses gcv in the presence of exogenous purines without glycine (30) . Lrp activates gcv but is insensitive to the coregulator leucine (7, 10) . In addition, PurR, a repressor protein involved in negatively regulating purine nucleotide synthesis (9, 18, 19) , also is involved in negative regulation of the GCV enzyme system (30) . Whether these proteins act through a common mechanism or function independently is unknown.
Previously, genetic and biochemical methods were used to define the promoter region for the gcv operon (15, 24) . The PurR-binding site was shown to overlap the gcv promoter (from about nucleotide -3 to + 17 relative to the transcription initiation site) (30) . Whether GcvA and Lrp bind directly to the gcv control region and where these proteins bind are unknown. To understand the DNA sequence elements required for gcv expression, we have extended the genetic and biochemical analysis of the gcv regulatory region. Our results suggest that the gcv regulatory region is complex, having several cis-acting regulatory sites required for gcv expression.
The results confirm that both GcvA and Lrp are required for expression of gcv and that sequences greater than 313 bp upstream of +1 are required for normal gcv expression. In addition, the results show that Lrp binds to multiple sites upstream of the gcv promoter, suggesting a direct role for Lrp in gcv expression.
MATERIALS AND METHODS
Bacterial strains, plasmids, and phage. The bacterial strains used in this study are listed in Table 1 . Phage Xgt2 (16) was obtained from R. Davis, and XcI857c17 (23) was obtained from M. Feiss. Plasmid vectors pBR322 (2) and pMC1403 (3) have been described previously. Plasmid pGS146 carries the gcv operon (25) .
Media. Luria broth and Luria agar were used as rich media (13) . The minimal medium was the minimal salts of Vogel and Bonner (27) supplemented with 0.4% glucose (GM medium). GM medium was always supplemented with phenylalanine and vitamin B1 since most strains carry the pheA905 thi mutations. Other supplements were added at the following concentrations (in micrograms per milliliter): amino acids, 50 (glycine was added at 300); vitamins, 1; ampicillin, 150; chloramphenicol, 20; tetracycline, 10; 5-bromo-4-chloro-3-indolyl-13-D-galactopyranoside (X-Gal), 40.
The X lysogens carry the c1857 mutation, resulting in a temperature-sensitive repressor, and were grown at 30°C. Lysogens were tested for a single copy of the bacteriophage by infection with XcI90c17 (23) .
Enzyme assays. I-Galactosidase activity was assayed as described by Miller (13) by using the chloroform-sodium Gel mobility shift assay. The gel mobility shift assay was based on the methods of Fried and Crothers (5) and Garner and Revzin (6) . A double-stranded 769-bp EcoRI-BamHI fragment carrying the gcv control region from plasmid pGS239 (24) was 32p labeled at the EcoRI end by using the large fragment of DNA polymerase I (21) . Less (Fig. 1) . Xgt2 phage carrying the deletions was used to lysogenize strain GS162, the lysogens were grown in GM medium with appropriate supplements, and ,-galactosidase levels were measured. As reported previously (24, 30, 31) , glycine induced gcvT-lacZ expression in lysogen GS162XTlac(A-466) more than sixfold (Table 2 ). In the presence of both glycine and inosine, the induced gcvT-lacZ expression was reduced about twofold compared with that in the presence of glycine alone as a result of PurR-mediated repression. In the absence of glycine, inosine repressed expression more than ninefold; this was shown previously to be a result of a combined repression by PurR and GcvA. Lysogen GS162XTlac(A-1167) has an additional 701 bp of upstream sequence compared with lyso- gen GS162XTlac(A-466). However, gcvT-lacZ expression is essentially the same in both lysogens ( Table 2 ), suggesting that sequences further upstream than position -466 are not necessary for normal gcv expression.
In lysogen GS162XTlac(A-313), gcvT-lacZ expression was reduced compared with that of lysogen GS162XTlac(A-466). However, glycine still induced gcvT-lacZ expression, and inosine still repressed gcvT-lacZ expression in both the presence and absence of glycine (Table 2 ). In lysogens GS162XTlac (A-169) and GS162XTlac(A-89), induction by glycine was abolished, and only the twofold PurR-mediated repression remained. To verify that this residual repression is PurR mediated, the purR mutant strain GS852 was lysogenized with XTlac(A-466), XTlac(A-313), and XTlac(A-169). In lysogen GS852XTlac(A-466), the twofold repression observed in the presence of both glycine and inosine compared with that in the presence of glycine alone was no longer seen (Table 2) . However, as reported previously (30) , inosine alone still repressed gcvT-lacZ expression via the GcvA protein. In lysogen GS852XTlac(A-313), although gcvT-lacZ expression was reduced compared with that of GS852XTlac(A-466), the PurRmediated repression was no longer seen in the presence of both glycine and inosine, but inosine alone still repressed gcvT-lacZ expression. In lysogen GS852XTlac(A-169), inosine supplementation no longer repressed gcvT-lacZ expression.
Effects of the deletion mutations in gcvA and lrp mutants. To determine the effects of the deletions in a strain lacking a GcvA activator protein, we lysogenized the gcvA mutant strain GS998 with phage XTlac(A-466), XTlac(A-313), and XTlac (A-169). The gevA mutant lysogen GS998XTlac(A-466) was noninducible by glycine and nonrepressible by inosine, except for the twofold PurR-mediated repression (Table 3 ). In lysogen GS998XTlac(A-313), again gcvT-lacZ expression was noniducible by glycine and nonrepressible by inosine, except for the twofold PurR-mediated repression. However, P-galactosidase levels were reduced about three-to fourfold under all growth conditions compared with those of GS998XTlac (A-466). A deletion ending at position -169 increased the basal level of expression about twofold compared with that of GS998XTlac(A-313), suggesting that a negative-acting site was removed. Again, gcvT-lacZ was noninducible by glycine and nonrepressible by inosine, except for the twofold PurRmediated repression.
To determine the effects of the deletions in a strain lacking the Lrp protein, we lysogenized the lrp mutant strain GS997 with phage XTlac(A-466), XTlac(A-313), and XTlac(A-169). In lysogen GS997XTlac(A-466), grown in GM medium, gcvTlacZ expression was about threefold lower than it was in the gcvA lysogen GS998XTAac(A-466) and was essentially noninducible by glycine (Table 3) . However, when cells were grown in the presence of both glycine and inosine, expression was reduced about twofold compared with cells grown in glycine alone, and in the presence of inosine alone, expression was reduced about threefold (Table 3 ).
In lysogen GS997XTlac(A-313), gcvT-lacZ expression was reduced under all conditions compared with that of lysogen GS997XTlac(A-466). AlthoughgcvT-lacZ expression was noninducible by glycine, repression by inosine was still observed, and this repression was more pronounced in the absence of glycine. A deletion ending at position -169 increased gcvTlacZ expression about threefold compared with that of GS997 XTlac(A-313), supporting the above results that a negativeacting site lies between positions -169 and -313. To determine whether the repression seen in GS997XTIac (A-466) by inosine alone was PurR or GcvA mediated, we also lysogenized GS997 with phage XTlac(A-466+8C+1OA) (+8C+1OA indicates that nucleotide +8 is changed to C and that nucleotide +10 is changed to A). This phage carries a 2-bp change in the PurR-binding site and prevents PurR-mediated repression of the gcyT-IacZ fusion (30) . In addition, the 2-bp change results in about a twofold promoter-down phenotype (30) . As shown in Table 3 , the twofold PurR-mediated repression of gcvT-lacZ is not seen when inosine is added to the glycine-containing culture. However, inosine alone still resulted in low but significant repression.
We also tested the effects of the deletions in the gcvA lrp double mutant GS1003. For the most part, 3-galactosidase levels were essentially the same as in the GS997 lIrp lysogens, with one notable exception. Lysogen GSO003XTlac(A-466 +8C+1OA), grown in the presence of inosine, did not show any significant purine-mediated repression (Table 3) .
Lrp.blding analysis. We used a gel mobility shift assay to determine whether the Lrp protein regulates gcv directly by binding to the gcv control region (see Materials and Methods).
A labeled DNA fragment carrying the gcv control region was shifted to at least four positions of slower mobility while the Lrp dimer concentration was increased from 0.27 to 69 nM (Fig. 3) . As the concentration of Lrp was increased, band A remained in small amounts, while band B increased to become the dominant species at 2 nM Lrp. Band C may be an DNase I footprint analysis. The gel mobility shift assay suggested that Lrp binds to multiple sites in the gcv control region. To determine where the Lrp protein binds in the gcv control region, we used a DNase I footprint assay (see Materials and Methods). As the Lrp dimer concentration was increased from 0.22 to 27.6 nM, Lrp bound to and protected sequences spanning about a 137-bp region from position -92 to position -229 (Fig. 4 , bars to the right of the gels). Within the protected region are sites that are either unprotected or that show enhanced cleavage. There are additional sites outside of the protected region that also show enhanced cleavage. At higher Lrp concentrations (Fig. 4, lanes 2 and 3) , Lrp appears to bind and protect nonspecifically, consistent with results from the gel mobility shift assay. Because DNase I did not cleave randomly, it is difficult to define precisely the boundaries of each target site or the precise boundaries of the Lrp-protected region.
DISCUSSION
Both the lxp and GcvA proteins are necessary for expression of the gcv operon (10, 31) . Deletions extending into the gcv control region from the 5' side to position -466 show normal induction by glycine and repression by inosine (Table   2) . A deletion ending at position -313 results in reduced expression ofgcv but still allows significant induction by glycine and repression by inosine. However, the observed repression by inosine alone is not reduced as much as the other conditions. Although the mechanism for the reduced expression in A&-313 is unknown, the deletion has not altered equally the abilities to activate by glycine and to repress by inosine. A deletion ending at position -169 abolishes both GevA-and Lrp-mediated activation as well as GcvA-mediated purine repression (Table 2 ). These results suggest that DNA-binding sites for one or both of these proteins is greater than 169 bp (Table 3 ). In the lrp or lrp gcvA mutant lysogens GS997 and GS1003, deletion of the sequence between -169 and -313 resulted in about a threefold increase in gcvT-lacZ expression under all growth conditions. In these mutant lysogens, the increase in gcvT-lacZ expression is raised only to the level found in the wild-type strain GS162XTlac(A-169) ( Table 2 ). These results suggest that there is an additional site that reduces gcv expression but only in the absence of the GcvA or Lrp protein.
One possibility is that the DNA sequence itself is important for gcv expression, possibly by bending DNA, or that this region could define a target site for an additional regulatory protein.
Studies to distinguish between these possibilities are in progress.
In the lrp lysogen GS997XTlac(A-466+8C+10A), glycine fails to induce gcvT-lacZ expression. However, inosine still resulted in about a twofold repression of gcvT-lacZ expression (Table 3 ). Since the PurR-binding site was inactivated by the 2-bp change (31) and Lrp was inactivated by the TnJO insertion, the results suggest that GcvA could be responsible for the purine-mediated repression. This conclusion is supported by results with lysogen GS1003XTlac(A-466+8C+10A), where both Lrp and GcvA are nonfunctional and no significant purine-mediated repression is observed. It should be noted, however, that the combination of the lrp and gcvA mutations and the promoter-down effect of the +8C+1OA base pair changes significantly reduce P-galactosidase levels. Nevertheless, the results suggest that GcvA could be responsible for the purine-mediated repression in lysogen GS997XT lac(A-466+8C+ 1OA) and that GcvA might be able to bind to DNA in the absence of Lrp to repress gcvT-lacZ expression.
Additional studies will be necessary to confirm or refute this hypothesis.
Lrp binds the ilvIH operon in two steps (28 (Fig. 3) . Results (29) .
Lrp-mediated activation of gcv is independent of leucine (7, 10 (Fig. 3) , suggesting that at least one of the binding sites has a high affinity for isp, and provide a possible explanation for the insensitivity of gcv to leucine. In a preliminary gel mobility shift assay, leucine (10 mM) reduced the affinity of Up for the gcv operon (data not shown). We are preparing overlapping DNA fragments with individual and multiple binding sites to determine their affinity for Lp, whether Lp binds cooperatively, and the effect of leucine on binding. These experiments, coupled with a genetic analysis, should define the sites necessary for Lrp-mediated activation of gcv.
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